NCT01544231View on ClinicalTrials.gov

Plasma Neutrophil Gelatinase Associated Lipocalin Levels During Emergency Management of Rhabdomyolysis

CompletedOBSERVATIONAL

Enrollment

197

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions

RhabdomyolysisAcute Kidney Failure

Interventions

BIOLOGICAL

Plasma NGAL level

The plasmatic level of Neutrophil Gelatinase Associated Lipocalin is measured in ng/ml/

Trial Locations (5)

30029

CHU de Nîmes - Hôpital Universitaire Carémeau, Nîmes

34295

CHU de Montpellier - Hôpital Lapeyronie, Montpellier

75651

APHP - Groupe Hospitalier Pitié-Salpetrière, Paris

83800

Hôpital Interarmées Sainte Anne, Toulon

06006

CHU de Nice - Hôpital St-Roch, Nice

All Listed Sponsors

lead

Centre Hospitalier Universitaire de Nīmes

OTHER

NCT01544231 - Plasma Neutrophil Gelatinase Associated Lipocalin Levels During Emergency Management of Rhabdomyolysis | Biotech Hunter | Biotech Hunter